Angiotensin type 1 receptor - Open Access .click

Results 131 to 140 of about 8,783 (159)

Some of the next articles are maybe not open access.

The Angiotensin II Type 1 Receptor Antagonists

Archives of Internal Medicine, 1995
The angiotensin II (AII) type 1 receptor antagonists represent a new pharmacologic class of drugs that are specifically designed to displace All from its type 1 receptor subtype. These drugs antagonize AII-induced biologic actions, including smooth-muscle contraction, sympathetic pressor mechanisms, and aldosterone release.
openaire +1 more source

Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blockers: A Multinational Cohort Study

Hypertension, 2021
Ruijun Chen, Marc A Suchard, Harlan M Krumholz +2 more
exaly

Effects of Angiotensin II Receptor Blockers and ACE (Angiotensin-Converting Enzyme) Inhibitors on Virus Infection, Inflammatory Status, and Clinical Outcomes in Patients With COVID-19 and Hypertension

Hypertension, 2020
Shaobin He
exaly

Angiotensin-type-1-receptor-agonists

Reactions Weekly, 2018
openaire +1 more source

Angiotensin type 1 receptor antagonists

Reactions Weekly, 2014
openaire +1 more source

Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19

Circulation Research, 2020
Peng Zhang, Lihua Zhu, Jingjing Cai
exaly

Angiotensin type-1 receptor antagonists

Reactions Weekly, 2015
openaire +1 more source